These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2970126)

  • 1. [Anuria, hepatocellular insufficiency and bone marrow aplasia after the administration of streptozocin and fluorouracil].
    Luquel L; Ekherian JM; De Gramont A; Offenstadt G
    Therapie; 1988; 43(2):125. PubMed ID: 2970126
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Hanley JA; Johnson LA
    N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of serious intolerance during treatment by phenindione: preventive measures to be taken].
    Manigand G; Auzépy P; Lardy C
    Sem Hop; 1968 Dec; 44(52):3217-22. PubMed ID: 4307331
    [No Abstract]   [Full Text] [Related]  

  • 5. Colorectal cancer (Duke's group B2, C1, C2): adjuvant chemotherapy and toxicity.
    Caruso U; Elli M; Cravotto E; Tisone G; Lombardo PA; Silvaroli M; Ficorella C; Cortesi E; Casciani CU
    Mt Sinai J Med; 1985 Jun; 52(6):470-2. PubMed ID: 3875028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complications with rifampicin treatment: one case with anuria (author's transl)].
    Chevalier JP; Plantier J; Kofman J; Montagnon B; Magnin F; Perrin-Fayolle M; Traeger J
    Poumon Coeur; 1980; 36(4):287-91. PubMed ID: 7443620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis-aplastic anemia syndrome (after the administration of chloramphenicol) (author's transl)].
    Ito M; Fukuiya Y
    Rinsho Ketsueki; 1974 Sep; 15(9):985-92. PubMed ID: 4612200
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Kvols LK; Ingle JN
    Cancer Treat Rep; 1979; 63(11-12):2105-6. PubMed ID: 230898
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of severe methacycline damage to the liver and bone marrow].
    Khadzhieva Zh; Chernev K; Iordanova E
    Vutr Boles; 1987; 26(6):115-7. PubMed ID: 3439145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung.
    Casper ES; Gralla RJ
    Cancer Treat Rep; 1979 Apr; 63(4):549-50. PubMed ID: 156068
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatorenal damage from toluene in a "glue sniffer".
    O'Brien ET; Yeoman WB; Hobby JA
    Br Med J; 1971 Apr; 2(5752):29-30. PubMed ID: 5550869
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-fluorouracil toxicity with severe bone marrow suppression in a dog.
    Fry MM; Forman MA
    Vet Hum Toxicol; 2004 Aug; 46(4):178-80. PubMed ID: 15303385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver damage following combined cytostatic therapy of breast cancer].
    Patakfalvi A; Gelencsér E; Sipos J
    Orv Hetil; 1986 Oct; 127(42):2561-2, 2565-6. PubMed ID: 3785942
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity.
    Ihde DC; Cohen MH; Bunn PA; Bernath AM; Broder LE; Minna JD
    Cancer Treat Rep; 1978 Jan; 62(1):155-7. PubMed ID: 75065
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.
    Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA
    Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.
    Turner NC; Strauss SJ; Sarker D; Gillmore R; Kirkwood A; Hackshaw A; Papadopoulou A; Bell J; Kayani I; Toumpanakis C; Grillo F; Mayer A; Hochhauser D; Begent RH; Caplin ME; Meyer T
    Br J Cancer; 2010 Mar; 102(7):1106-12. PubMed ID: 20234360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin.
    Klotz HP; Weder W; Largiadèr F
    Helv Chir Acta; 1993 Sep; 60(1-2):283-6. PubMed ID: 8226075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids and fluorouracil toxicity.
    Horton J; Olson KB; Hosley HF
    Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
    Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
    Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.